MMMarco Moscatelli

Marco Moscatelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marco Moscatelli has a total of 302 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The “Kiss Swan” Sign

    by Chiara Benzoni, Marco Moscatelli, Daniela Di Bella, Stefania Magri, Ettore Salsano

  • Sylvian Fissure Meningioma in a Child With KRAS-Related Noonan Syndrome

    by Germana Lo Monaco, Gianluca Marucci, Laura Grazia Valentini, Silvia Masnada, Marco Moscatelli, Veronica Saletti

  • Open Access

    Use of Brain MRI in Cerebral Adrenoleukodystrophy

    by Hemmo A.F. Yska, Marianne Golse, Damien Galanaud, Hernan M. Amartino, Caroline Bergner, Fabio Bruschi, Florian S. Eichler, Ali Fatemi, ÀNgeles García-Cazorla, Marta Gomez-Chiari, et al.

    Background and ObjectivesCerebral adrenoleukodystrophy (CALD) is a common manifestation of adrenoleukodystrophy (ALD) in men. Early detection of CALD lesions through MRI screening is critical to al...


  • Open Access

    Adrenoleukodystrophy in adults: phenotypic characterisation and natural history in a large cohort

    by Chiara Benzoni, Marco Moscatelli, Paola Lanteri, Viviana Pensato, Chiara Calò, Simona Allievi, Cinzia Gellera, Anna Ardissone, Isabella Moroni, Silvia Fenu, et al.

    Background: Adult adrenoleukodystrophy is a rare X linked disorder with heterogeneous phenotypes, complicating prognosis and trial design. We characterised phenotype and natural history in a large single-centre nationwide cohort and contextualised findings with prior reports. Methods: We performed a combined retrospective-prospective observational study of adults (≥18 years) with confirmed ABCD1 variants evaluated at Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan (January 2004–June 2023), with reassessments between July and December 2023. Clinical, genetic, biochemical, MRI and neurophysiological data were analysed. Results: The cohort comprised 140 patients (64 males, 76 females) from 58 families, carrying 50 ABCD1 variants, including 11 novel mutations. Adrenomyeloneuropathy (AMN) predominated in males, with low mortality (<10%) and rare cerebral progression (7%) across 18 years, suggesting protective factors. An intermediate phenotype, adrenoleukomyeloneuropathy (ALMN), showed earlier onset, demyelinating MRI changes without cerebral symptoms at baseline and higher mortality than AMN (HR 4.75, 95% CI 1.60 to 14.11). In females, symptom prevalence increases with age, affecting 57% over 60, although only 37% required walking aids. Males had higher very long-chain fatty acid (VLCFA) levels than females, but intrasex correlations with phenotype were absent. Brainstem auditory evoked potentials (BAEPs) were consistently abnormal, whereas nerve conduction studies were abnormal in ~half of male patients (less often in females). Conclusions: Adult adrenoleukodystrophy comprises distinct phenotypes with variable prognosis. Recognition of ALMN as an intermediate form and the low cerebral progression rate in Italian AMN refine disease classification. Sex-related VLCFA differences may influence severity, although standard assays lack sensitivity. Neurophysiological testing, particularly BAEPs, can support differential diagnosis in patients with hereditary spastic paraplegias. Trial registration number: NCT04880356 .

  • Open Access

    Whole‐Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies

    by Laura Costa‐Comellas, Mauro Monforte, Angel Sanchez‐Montañez, Penélope Romero‐Duque, Elena Pegoraro, Jordi Díaz‐Manera, Dmitry Vlodavets, Lorenzo Maggi, Marco Moscatelli, Adele D‘aMico, et al.

    Objective: To characterize whole‐body intramuscular fat distribution pattern in patients with sarcoglycanopathies and explore correlations with disease severity, duration and age at onset. Methods: Retrospective, cross‐sectional, multicentric study enrolling patients with variants in one of the four sarcoglycan genes who underwent whole‐body muscle MRI. Intramuscular fatty replacement was evaluated on T1‐weighted images and represented by heatmaps. Dimensionality reduction and linear spline models examined relationships between patterns of intramuscular fat replacement and clinical findings. Results: MRI scans from 64 patients (age range 4–67 years) covering 4160 muscles were analyzed. Disease severity ranged from asymptomatic (9%) to non‐ambulant (39%) patients. Sarcoglycanopathies showed consistent, selective patterns of muscle involvement across genotypes. Latissimus dorsi and subscapularis were the earliest affected muscles in the upper body, whereas head, neck and forearm muscles remained largely preserved. Distinct gradients characterized the topography of degeneration both within individual muscles and along body and limb axes. Disease severity correlated with MRI changes in both upper and lower body muscles, and with one of the dimensions identified by the multi‐correspondence analysis. Patients with onset in the first decade showed a steeper cross‐sectional association between disease duration and MRI abnormalities, while later‐onset patients displayed a more gradual, linear relationship. Interpretation: Sarcoglycanopathies display selective muscle vulnerability with characteristic gradients of fat replacement. Scapular girdle muscles are affected early in the disease course. Intramuscular fat correlates with functional impairment and disease duration, supporting its use as a surrogate endpoint in clinical trials. Age at onset emerges as a critical prognostic factor.

  • Teaching NeuroImage: Distinctive White Matter Abnormalities in KIF1C Pathogenic Variants

    by Veronica Saletti, Mariagiovanna Melillo, Marco Moscatelli, Stefania Magri, Franco Taroni, Alessandra Erbetta


  • Open Access

    Exploring foundation models for multi-class muscle segmentation in MR images of neuromuscular disorders: A comparative analysis of accuracy and uncertainty

    by Nicola Casali, Nicola Casali, Alessandro Brusaferri, Alessandro Brusaferri, Giuseppe Baselli, Giuseppe Baselli, Marco Moscatelli, Marco Moscatelli, Domenico Aquino, Domenico Aquino, et al.


  • Open Access

    Self-silencingGFAPmissense alleles in familial subclinical Alexander disease: implications for therapy

    by Tiziana Bachetti, Stefania Magri, Francesca Balistreri, Francesca Rosamilia, Simona Coco, Camillo Rosano, Marco Moscatelli, Elisa Sarto, Daniela Di Bella, Ettore Salsano, et al.


  • Open Access

    Bilateral optic neuropathy as first neurological sign of Central Nervous System (CNS) involvement in indolent chronic lymphocytic leukemia

    by Paola Ciasca, Sebastiano Crisafulli, Ludovica Gargiulo, Stefania Bianchi Marzoli, Massimo Magagnoli, Marco Moscatelli, Elena Anghileri

  • Open Access

    The Role of Amide Proton Transfer (APT)-Weighted Imaging in Glioma: Assessment of Tumor Grading, Molecular Profile and Survival in Different Tumor Components

    by Gonçalo Borges de Almeida, Riccardo Pascuzzo, Francesca Mambrin, Domenico Aquino, Mattia Verri, Marco Moscatelli, Massimiliano Del Bene, Francesco DiMeco, Antonio Silvani, Bianca Pollo, et al.

    Amide Proton Transfer-weighted (APTw) imaging is a molecular MRI technique used to quantify protein concentrations in gliomas, which have heterogeneous components with varying cellularity and metabolic activity. This study aimed to assess the correlation between the component-specific APT signal of the neoplasm and WHO grade, molecular profile and survival status. Sixty-one patients with adult-type diffuse gliomas were retrospectively analyzed. APT values were semi-automatically extracted from tumor solid and, whenever present, necrotic components. APT values were compared between groups stratified by WHO grade, IDH-mutation, MGMT promoter methylation and 1- and 2-year survival status using Wilcoxon rank-sum test, adjusting for multiple comparisons. Overall survival (OS) was analyzed in the subgroup of 48 patients with grade 4 tumors using Cox proportional-hazards models. Random-effects models were used to assess inter-subject heterogeneity of the mean APT values in each tumor component. APT values of the solid component significantly differed between patients with grades 2–3 and 4 tumors (mean 1.58 ± 0.50 vs. 2.04 ± 0.56, p = 0.028) and correlated with OS after 1 year (1.81 ± 0.58 in survivors vs. 2.17 ± 0.51 in deceased patients, p = 0.030). APT values did not differ by IDH-mutation, MGMT methylation, and 2-year survival status. Within grade 4 glioma patients, higher APT kurtosis of the solid component was a negative prognostic factor (hazard ratio = 1.60, p = 0.040). Mean APT values of the necrosis showed high inter-subject variability, although most necrotic tumors were grade 4 and IDH wildtype. In conclusion, APTw imaging in the solid component provided metrics associated with glioma grade and survival status but showed weak correlation with IDH-mutation and MGMT promoter methylation status, in contrast to previous works. Further research is needed to understand APT signal variability within the necrotic component of high-grade gliomas.